The proportion of basic medical insurance participants and urban and rural residents' medical insurance fund payment is 80%. After dabituo was included in the national medical insurance catalogue, it met the urgent needs of patients with atopic dermatitis for breakthrough innovative drugs, and played a vital role in strengthening patients' long-term medication compliance and promoting the overall treatment level of atopic dermatitis in China.
Dupuyizumab injection is a whole human monoclonal antibody, and it is the first and only targeted biological agent in the world approved for the treatment of moderate and severe atopic dermatitis in adults.
The side effects of dabituo mainly include allergies, eye problems and infections.
1. Allergy: People who are allergic to dabituo may have allergic side effects after using this product, including rash, redness, elevated body temperature, dizziness and joint pain. Some patients may have serious side effects, such as dyspnea and syncope. Need to stop taking medicine immediately and seek medical advice in time;
2, eye problems: when using dabituo, it may have an impact on the patient's eyes, such as pain, itching, conjunctivitis or changing the patient's vision;
3. Infection: Dabito needs to be injected into the human body to treat diseases. In the process of injection, it may increase the possibility of local redness, itching and other infections, or increase the number of injections, leading to local induration.
legal ground
People's Republic of China (PRC) social insurance law
Article 2 The state establishes social insurance systems such as basic old-age insurance, basic medical insurance, industrial injury insurance, unemployment insurance and maternity insurance, so as to guarantee citizens' right to receive material assistance from the state and society in accordance with the law in case of old age, illness, industrial injury, unemployment and maternity.
Twenty-sixth basic medical insurance for employees, new rural cooperative medical care and basic medical insurance for urban residents shall be implemented in accordance with state regulations.
Twenty-eighth medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency treatment and rescue shall be paid by the basic medical insurance fund in accordance with state regulations.